Berkeley Eye Center

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Berkeley Eye Center sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials 2 currently recruiting 6 completed later-stage tilt upper quartile by trial count

Berkeley Eye Center: 8 sponsored US clinical trials, 2 recruiting.

Berkeley Eye Center sponsors 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 6 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 1 trials.

Upper-quartile sponsor footprint

Berkeley Eye Center sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

8 total, page 1 of 1

RECRUITING Phase 4

A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects

NCT07693205
RECRUITING Phase 4

A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects

NCT06922084
COMPLETED

Comparison of Two Biometers in Dense Cataracts

NCT07475832
COMPLETED

Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients

NCT06064916
COMPLETED

Assessment of Measurement Variability Across Automated Biometry Devices

NCT06045325
COMPLETED

Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

NCT06041139
COMPLETED

Maximizing Visual Outcomes With Eyhance IOLs

NCT05611073
COMPLETED

Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs

NCT05226884

Phase Distribution

PhaseTrial count
Phase 4 2

Therapeutic Areas

Cataract 1

Where Berkeley Eye Center enrollment is open (later-stage tilt)

2 recruiting of 8 indexed (25% open); 6 completed (75%).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Cataract (1 trial), 0 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Berkeley Eye Center: open-pipeline peers nationwide

Peers matched on 8 registered trials and 25% open enrollment, not the therapeutic-area sidebar.

Berkeley Eye Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 3456789 0%10%20%30%40% Total trials Recruiting share Berkeley Eye CenterAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Abdul Latif Jameel Poverty Action LabAccutar BiotechnologyAdrienne G. WaksAdvocate Hospital System
Berkeley Eye Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Berkeley Eye Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 trials (± recruiting share)

Sponsors near 25% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Berkeley Eye Center page

8 registered trials is a research-attention snapshot, not an endorsement of Berkeley Eye Center or any single study.

  • 2 of Berkeley Eye Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cataract is the condition Berkeley Eye Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Berkeley Eye Center pipeline card: 8 registered trials from official public datasets.Report a data error.